English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Carcinoma of the bladder is the most prevalent cancer in Egypt. At the National Cancer Institute (NCI), Cairo University, it constitutes 10.1% of all cancers for both sexes together1. In addition to the unique biological, epidemiological, pathological and clinical characteristics of bilharzial bladder cancer compared with the conventional transitional cell carcinoma seen in Western countries2, the disease also has a different chemoresponsiveness profile, as reported in a series of phase II single-agent and combination chemotherapy trials3,4.

research in oncology

Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin In Advanced and or Metastatic Bilharzial Urothelial Carcinoma of the Bladder in Egypt.